Bayer appeals $78M verdict in landmark Monsanto glyphosate-cancer lawsuit

Agribusiness giant Monsanto on [November 20] appealed a $78 million verdict in favor of a dying California man who said the company’s widely used Roundup weed killer was a major factor in his cancer.

The company filed a notice of appeal in San Francisco Superior Court challenging a jury verdict in favor of DeWayne Johnson. In August, the jury unanimously found that Roundup caused Johnson’s non-Hodgkin’s lymphoma and awarded him $289 million.

“We continue to believe that the liability verdict and reduced damage award are not supported by the evidence at trial or the law,” Bayer, which acquired Monsanto in June, said in a statement. Bayer said none of the science presented at trial supported the conclusion that Roundup was a substantial cause of Johnson’s cancer.

Related article:  Despite $10.9 billion US glyphosate-cancer settlement, Australia officially maintains weedkiller 'perfectly safe'

An email to a spokeswoman for Johnson’s attorneys was not immediately returned.

Many government regulators have rejected a link between glyphosate and cancer. Monsanto says hundreds of studies have established that glyphosate is safe.

Read full, original article: Monsanto Appeals $78M Verdict in California Weed Killer Suit

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend